Ipa-Pharmacies Limited
04613543
Healthy
No risk factors detected.
Details
Compliance
Last accounts
31/03/2025
total exemption full
Next accounts due
31/12/2026
Confirmation statement
Last: 10/12/2025
Due 24/12/2026
Industry
Officers
director · Since 21/10/2014
PHARMACIST
BRITISH · UNITED KINGDOM · Age 61
Also on 13 other boards
director · Since 21/10/2014
COMPANY DIRECTOR / PHARMACIST
BRITISH · ENGLAND · Age 58
Also on 17 other boards
director · Since 26/03/2019
EXECUTIVE DIRECTOR
BRITISH · ENGLAND · Age 46
Also on 8 other boards
director · Since 26/11/2019
PHARMACIST
IRISH · UNITED KINGDOM · Age 58
Also on 4 other boards
secretary · Since 01/04/2020
director · Since 25/09/2020
PHARMACIST
BRITISH · ENGLAND · Age 60
Also on 1 other board
director · Since 01/03/2023
PHARMACIST
BRITISH · UNITED KINGDOM · Age 65
Also on 2 other boards
CompanyRankvs 1771+ SIC 94990 peers70
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 31/03/2025
Net Worth
£25k
Balance sheet strength
Cash
£290k
Cash in the bank
Net Current Assets
£25k
Working capital
Current Assets
£341k
Current Liabilities
£316k
Debtors
£51k
Tax at Year End(2024)
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit | Est. Revenue |
|---|---|---|---|
| 2025 | 1.08 | -£65k | — |
| 2024 | 1.31 | +£328k | £774k |
| 2023 | 0.05 | -£335k | — |
| 2022 | 1.27 | +£30k | — |
| 2021 | 1.24 | +£60k | — |
| 2020 | 1.02 | -£14k | — |
| 2019 | 1.08 | — | — |
Derived from filed accounts. Not audited figures.